News

Enveric Biosciences Receives Notice of Allowance for New Class of Low-Hallucinogenic Neuroplastogens Targeting Psychiatric Disorders
Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company advancing next-generation ...
9% Dividends: 2 Retirement Income Powerhouses
Two 9% yielding instruments that serve as great examples of why it is still worth giving such securities a benefit of the ...